Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Invicta Diagnostic Limited (NSE: INVICTA), ISIN INE0XJ501010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
INVICTA last traded at ₹73.50 (+6.21%), with a 52-week range of ₹58.10 to ₹105.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 66.70%, FIIs 1.54%, DIIs 4.25%, mutual funds 0.00%.
EquiSense Score (ECS): 51/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.